1. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial. Issue 8 (August 2019) Authors: Herbst, Roy S; Arkenau, Hendrik-Tobias; Santana-Davila, Rafael; Calvo, Emiliano; Paz-Ares, Luis; Cassier, Philippe A; Bendell, Johanna; Penel, Nicolas; Krebs, Matthew G; Martin-Liberal, Juan; Isambert, Nicolas; Soriano, Andres; Wermke, Martin; Cultrera, Jennifer; Gao, Ling; Widau, Ryan C; Mi, Gu;... Journal: Lancet oncology Issue: Volume 20:Issue 8(2019) Page Start: 1109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification. (December 2017) Authors: Angevin, Eric; Spitaleri, Gianluca; Rodon, Jordi; Dotti, Katia; Isambert, Nicolas; Salvagni, Stefania; Moreno, Victor; Assadourian, Sylvie; Gomez, Corinne; Harnois, Marzia; Hollebecque, Antoine; Azaro, Analia; Hervieu, Alice; Rihawi, Karim; De Marinis, Filippo Journal: European journal of cancer Issue: Volume 87(2017) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Exosomes in cancer theranostic: Diamonds in the rough. Issue 2 (4th March 2017) Authors: Cordonnier, Marine; Chanteloup, Gaëtan; Isambert, Nicolas; Seigneuric, Renaud; Fumoleau, Pierre; Garrido, Carmen; Gobbo, Jessica Journal: Cell adhesion & migration Issue: Volume 11:Issue 2(2017) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancer. (October 2019) Authors: Truntzer, Caroline; Isambert, Nicolas; Arnould, Laurent; Ladoire, Sylvain; Ghiringhelli, Francois Journal: European journal of cancer Issue: Volume 120(2019) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Exceptional Long-lasting Clinical Benefit of Trabectedin in a Patient With Metastatic Undifferentiated Pleomorphic Sarcoma: Postscriptum From the T-Dis Trial. (September 2019) Authors: Penel, Nicolas; Decoupigny, Emilie; Tresch-Bruneel, Emmanuelle; Le Cesne, Axel; Taieb, Sophie; Isambert, Nicolas Journal: American journal of clinical oncology Issue: Volume 42:Number 9(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113). Issue 10 (15th June 2020) Authors: Ray-Coquard, Isabelle; Hatcher, Helen; Bompas, Emmanuelle; Casado, Antonio; Westermann, Annekke; Isambert, Nicolas; Casali, Paolo Giovanni; Pratap, Sarah; Stark, Daniel; Valverde, Claudia; Anand, Anjana; Huizing, Manon; Floquet, Anne; Lindner, Lars; Hermes, Barbara; Seddon, Beatrice; Coens, Corne... Journal: International journal of gynecological cancer Issue: Volume 30:Issue 10(2020) Page Start: 1633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 361 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 12 month analysis of biomarkers and clinical outcomes. (10th December 2020) Authors: Jaderberg, Magnus; Cedres, Susana; Paz-Ares, Luis; Serres, Xavier; Ricordel, Charles; Isambert, Nicolas; Aix, Santiago Ponce; Levitsky, Victor; Kuryk, Lukasz; Moller, Anne-Sophie; Vetrhus, Sylvia Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 361 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 12 month analysis of biomarkers and clinical outcomes. (9th November 2020) Authors: Jaderberg, Magnus; Cedres, Susana; Paz-Ares, Luis; Serres, Xavier; Ricordel, Charles; Isambert, Nicolas; Aix, Santiago Ponce; Levitsky, Victor; Kuryk, Lukasz; Moller, Anne-Sophie; Vetrhus, Sylvia Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE. (October 2021) Authors: Schöffski, Patrick; Kubickova, Michaela; Wozniak, Agnieszka; Blay, Jean-Yves; Strauss, Sandra J.; Stacchiotti, Silvia; Switaj, Tomasz; Bücklein, Veit; Leahy, Michael G.; Italiano, Antoine; Isambert, Nicolas; Debiec-Rychter, Maria; Sciot, Raf; Lee, Che-Jui; Speetjens, Frank M.; Nzokirantevye, Axel... Journal: European journal of cancer Issue: Volume 156(2021) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial. Issue 5 (May 2016) Authors: Mir, Olivier; Cropet, Claire; Toulmonde, Maud; Cesne, Axel Le; Molimard, Mathieu; Bompas, Emmanuelle; Cassier, Philippe; Ray-Coquard, Isabelle; Rios, Maria; Adenis, Antoine; Italiano, Antoine; Bouché, Olivier; Chauzit, Emmanuelle; Duffaud, Florence; Bertucci, François; Isambert, Nicolas; Gautier,... Journal: Lancet oncology Issue: Volume 17:Issue 5(2016:May) Page Start: 632 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗